EVALUATION OF NEOADJUVANT CHEMOTHERAPY RESPONSE IN PATIENTS WITH OVARIAN CANCER – MODERN ABILITIES OF MAGNETIC RESONANCE IMAGING
The purpose – to evaluate the capability of the integrated magnetic resonance imaging (MRI) with diffusion sequences in the assessment of neoadjuvant chemotherapy treatment response of ovarian cancer.Materials and methods. 23 patients with disseminated stages of ovarian cancer underwent pelvic and a...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2017-03-01
|
| Series: | Акушерство, гинекология и репродукция |
| Subjects: | |
| Online Access: | https://www.gynecology.su/jour/article/view/365 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839583523259809792 |
|---|---|
| author | A. D. Makatsariya A. E. Solopova S. N. Gurov S. K. Ternovoy |
| author_facet | A. D. Makatsariya A. E. Solopova S. N. Gurov S. K. Ternovoy |
| author_sort | A. D. Makatsariya |
| collection | DOAJ |
| description | The purpose – to evaluate the capability of the integrated magnetic resonance imaging (MRI) with diffusion sequences in the assessment of neoadjuvant chemotherapy treatment response of ovarian cancer.Materials and methods. 23 patients with disseminated stages of ovarian cancer underwent pelvic and abdominal MRI to clarify the tumor spread, the issue of neoadjuvant chemotherapy (NHT) and again after 1 and 3 courses in the evaluation of its effectiveness. MR-study was performed on a superconductive 1.5 T MRI, using protocol: T2-, stir, T1-, Dynamic 3D FS, DWI with b-factors 0,1000 m/mm2 , with an estimate value of the apparent diffusion coefficient (ADC). The evaluation of differences in size of the entities was performed in accordance with RECIST 1.1 criteria, parameter measured: ADC.Results. Сomparative assessment of ADC before and after treatment revealed significant increase after 3 courses of chemotherapy (p=0.008), improvement after 1 course in the primary tumor and differences in the ADC before and after treatment in the omental and the peritoneal implants are less pronounced and insignificant (R=0.89; 0.758; 0.695 respectively). Informativity in evaluation of residual tumor and the degree of therapeutic pathomorphosis MRI were: sensitivity 93.3%, specificity 84.6%, and accuracy 91.3%.Conclusions. Diffusion MRI has high informativity and reproducibility in determination of response to neoadjuvant chemotherapy in advanced ovarian cancer. A significant difference in the mean ADC values was obtained for the solid component of the primary tumors, suggesting greater sensitivity to neoadjuvant chemotherapeutic treatment. |
| format | Article |
| id | doaj-art-a8c7e57d5e5d49d5b43ec9cecf62d110 |
| institution | Matheson Library |
| issn | 2313-7347 2500-3194 |
| language | Russian |
| publishDate | 2017-03-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Акушерство, гинекология и репродукция |
| spelling | doaj-art-a8c7e57d5e5d49d5b43ec9cecf62d1102025-08-03T19:55:14ZrusIRBIS LLCАкушерство, гинекология и репродукция2313-73472500-31942017-03-0110451110.17749/2313-7347.2016.10.4.005-011355EVALUATION OF NEOADJUVANT CHEMOTHERAPY RESPONSE IN PATIENTS WITH OVARIAN CANCER – MODERN ABILITIES OF MAGNETIC RESONANCE IMAGINGA. D. Makatsariya0A. E. Solopova1S. N. Gurov2S. K. Ternovoy3FSBEI HE I.M. Sechenov First MSMU MOH RussiaFSBEI HE I.M. Sechenov First MSMU MOH RussiaCancer clinical dispensary №1 Department of Health of MoscowFSBEI HE I.M. Sechenov First MSMU MOH RussiaThe purpose – to evaluate the capability of the integrated magnetic resonance imaging (MRI) with diffusion sequences in the assessment of neoadjuvant chemotherapy treatment response of ovarian cancer.Materials and methods. 23 patients with disseminated stages of ovarian cancer underwent pelvic and abdominal MRI to clarify the tumor spread, the issue of neoadjuvant chemotherapy (NHT) and again after 1 and 3 courses in the evaluation of its effectiveness. MR-study was performed on a superconductive 1.5 T MRI, using protocol: T2-, stir, T1-, Dynamic 3D FS, DWI with b-factors 0,1000 m/mm2 , with an estimate value of the apparent diffusion coefficient (ADC). The evaluation of differences in size of the entities was performed in accordance with RECIST 1.1 criteria, parameter measured: ADC.Results. Сomparative assessment of ADC before and after treatment revealed significant increase after 3 courses of chemotherapy (p=0.008), improvement after 1 course in the primary tumor and differences in the ADC before and after treatment in the omental and the peritoneal implants are less pronounced and insignificant (R=0.89; 0.758; 0.695 respectively). Informativity in evaluation of residual tumor and the degree of therapeutic pathomorphosis MRI were: sensitivity 93.3%, specificity 84.6%, and accuracy 91.3%.Conclusions. Diffusion MRI has high informativity and reproducibility in determination of response to neoadjuvant chemotherapy in advanced ovarian cancer. A significant difference in the mean ADC values was obtained for the solid component of the primary tumors, suggesting greater sensitivity to neoadjuvant chemotherapeutic treatment.https://www.gynecology.su/jour/article/view/365metabolic syndromeobesitygestational complicationspolymorphismsthrombophilia |
| spellingShingle | A. D. Makatsariya A. E. Solopova S. N. Gurov S. K. Ternovoy EVALUATION OF NEOADJUVANT CHEMOTHERAPY RESPONSE IN PATIENTS WITH OVARIAN CANCER – MODERN ABILITIES OF MAGNETIC RESONANCE IMAGING Акушерство, гинекология и репродукция metabolic syndrome obesity gestational complications polymorphisms thrombophilia |
| title | EVALUATION OF NEOADJUVANT CHEMOTHERAPY RESPONSE IN PATIENTS WITH OVARIAN CANCER – MODERN ABILITIES OF MAGNETIC RESONANCE IMAGING |
| title_full | EVALUATION OF NEOADJUVANT CHEMOTHERAPY RESPONSE IN PATIENTS WITH OVARIAN CANCER – MODERN ABILITIES OF MAGNETIC RESONANCE IMAGING |
| title_fullStr | EVALUATION OF NEOADJUVANT CHEMOTHERAPY RESPONSE IN PATIENTS WITH OVARIAN CANCER – MODERN ABILITIES OF MAGNETIC RESONANCE IMAGING |
| title_full_unstemmed | EVALUATION OF NEOADJUVANT CHEMOTHERAPY RESPONSE IN PATIENTS WITH OVARIAN CANCER – MODERN ABILITIES OF MAGNETIC RESONANCE IMAGING |
| title_short | EVALUATION OF NEOADJUVANT CHEMOTHERAPY RESPONSE IN PATIENTS WITH OVARIAN CANCER – MODERN ABILITIES OF MAGNETIC RESONANCE IMAGING |
| title_sort | evaluation of neoadjuvant chemotherapy response in patients with ovarian cancer modern abilities of magnetic resonance imaging |
| topic | metabolic syndrome obesity gestational complications polymorphisms thrombophilia |
| url | https://www.gynecology.su/jour/article/view/365 |
| work_keys_str_mv | AT admakatsariya evaluationofneoadjuvantchemotherapyresponseinpatientswithovariancancermodernabilitiesofmagneticresonanceimaging AT aesolopova evaluationofneoadjuvantchemotherapyresponseinpatientswithovariancancermodernabilitiesofmagneticresonanceimaging AT sngurov evaluationofneoadjuvantchemotherapyresponseinpatientswithovariancancermodernabilitiesofmagneticresonanceimaging AT skternovoy evaluationofneoadjuvantchemotherapyresponseinpatientswithovariancancermodernabilitiesofmagneticresonanceimaging |